Betrixaban approved in the USA for Medical Prophylaxis for high risk patients

In a recent article in the New England Journal of Medicine a trial involving Betrixaban, a direct factor Xa inhibitor, in extended prophylaxis for acutely unwell medical patients comparing this with Enoxaparin injections. The full article can be accessed here http://www.nejm.org/doi/full/10.1056/NEJMoa1601747#t=abstract

 

This medication however is currently only licensed in the United States where it has received FDA approval and can not currently be used in Europe